<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The long-acting effect of a 10-min pulse infusion of the beta 2-<z:chebi fb="0" ids="37886">adrenergic agonist</z:chebi> fenoterol on oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance tests in controls and in normotensive patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> on diet was compared </plain></SENT>
<SENT sid="1" pm="."><plain>During an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> load starting 2 h after fenoterol control persons showed <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (area: 25,950 +/- 467 vs. 22,650 +/- 410, P less than 0.01), <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> (area: 13,980 +/- 1050 vs. 8160 +/- 405, P less than 0.02) and a pronounced fall of serum <z:chebi fb="120" ids="26216">potassium</z:chebi> (area: 775 +/- 26 vs. 748 +/- 25, P less than 0.02) </plain></SENT>
<SENT sid="2" pm="."><plain>The patient group showed no late response to fenoterol: plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (area: 51,000 +/- 382 vs. 51,300 +/- 413, n.s.), serum insulin (area: 7215 +/- 233 vs. 8280 +/- 410, n.s.), serum <z:chebi fb="120" ids="26216">potassium</z:chebi> (area: 748 +/- 26 vs. 750 +/- 24, n.s.) </plain></SENT>
<SENT sid="3" pm="."><plain>The data show that there is a defect of the beta 2-adrenergic long-acting effect on <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and on insulin release in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
</text></document>